Literature DB >> 10469832

The molecular weight ratio of monomethoxypolyethylene glycol (mPEG) to protein determines the immunotolerogenicity of mPEG proteins.

T So1, H O Ito, Y Tsujihata, M Hirata, T Ueda, T Imoto.   

Abstract

Immunotolerogenic activity of monomethoxypolyethylene glycol- (mPEG) conjugated proteins is a beneficial property in protein pharmaceutics. However, procedures for the preparation of tolerogenic mPEG proteins have not yet been defined. We prepared mPEG proteins with different mPEG contents using three proteins, hen egg lysozyme, ovalbumin and bovine gamma globulin, and their tolerogenicities to antigen-specific T and B cell responses were examined. We found the most appropriate ratio of tolerance induction to be 1.5-2.0, which is the molecular weight ratio of conjugated total mPEGs to protein. This value may assist in the preparation of tolerogenic mPEG proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469832     DOI: 10.1093/protein/12.8.701

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  4 in total

1.  "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung.

Authors:  M A Croyle; N Chirmule; Y Zhang; J M Wilson
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  PEGylated Adenoviruses: From Mice to Monkeys.

Authors:  Piyanuch Wonganan; Maria A Croyle
Journal:  Viruses       Date:  2010-02-01       Impact factor: 5.818

3.  In vivo anti-tumor activity of polypeptide HM-3 modified by different polyethylene glycols (PEG).

Authors:  Zhendong Liu; Yinling Ren; Li Pan; Han-Mei Xu
Journal:  Int J Mol Sci       Date:  2011-04-19       Impact factor: 5.923

4.  A method to induce hen egg lysozyme-specific humoral immune tolerance in mice by pre-exposition with the protein's oligomers.

Authors:  Takatoshi Ohkuri; Natsuko Yuge; Kenji Sato; Tadashi Ueda
Journal:  Biochem Biophys Rep       Date:  2019-08-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.